Autoimmune Lymphoproliferative Syndrome Panel
NY Approved
Test Overview
Clinical Utility
- Confirmation of the clinical diagnosis.
- Differentiation from malignant forms of lymphoproliferation.
- Distinguish sub-type of ALPS.
- Development of an appropriate treatment plan for affected individuals.
- Development of an appropriate medical surveillance plan for relatives at risk of lymphoma.
Test Details
Genes
CASP10, CASP8, FASLG, TNFRSF6
Conditions
- Autoimmune Lymphoproliferative Syndrome (ALPS) Type 1A
- Autoimmune Lymphoproliferative Syndrome Type IIA (ALPS IIA)
- Autoimmune Lymphoproliferative Syndrome Type IIB (ALPS IIB)
Lab Method
- Deletion/Duplication Analysis
- Next-Gen Sequencing
Ordering Information
Resources
Test Documents
Billing
Targeted Variant Testing